Effectiveness of SB5, an Adalimumab Biosimilar, in Patients With Noninfectious Uveitis: A Real-Life Monocentric Experience
Sign Up to like & getrecommendations! Published in 2021 at "Asia-Pacific Journal of Ophthalmology"
DOI: 10.1097/apo.0000000000000380
Abstract: Purpose: Several concerns have arisen with biosimilars in terms of immunogenicity, safety issues, loss of efficacy, and extrapolation to other indications. The study aim was to evaluate the efficacy of SB5, an adalimumab biosimilar, in… read more here.
Keywords: last follow; noninfectious uveitis; uveitis relapses; sb5 ... See more keywords